Devyser Thalassemia v2 is a fast and robust NGS solution designed for the detection of genetic variants in alpha and beta thalassemia. It offers comprehensive coverage of the globin genes HBA1, HBA2, HBB, HBD, HBG1, and HBG2, and includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number variations (CNVs). Additionally, it detects beta-hemoglobin modifiers such as BCL11A and KLF1.

Devyser Thalassemia v2 Workflow

Key Features

Comprehensive variant detection: Identifies relevant genetic variants of alpha and beta thalassemia, as well as their modifiers.
Advanced CNV: Detects complex copy number variations (CNVs) in the alpha and beta globin gene regions, including the α3.7 and α4.2 deletions.
Long-range PCR (LR-PCR): Enables accurate detection of complex deletions in alpha thalassemia.
Low hands-on time: Streamlined workflow for fast results with same-day library preparation.
Thalassemia Analysis 1 Thalassemia Analysis 2

Dedicated software: Provides automated, user-friendly analysis, with options for batch export and efficient variant analysis without the need for bioinformatics expertise.

Devyser Thalassemia Software

Genes Covered

HBA1, HBA2: Alpha-globin genes. HBB: Beta-globin. HBD: Delta-globin. HBG1, HBG2: Gamma-globin. Beta thalassemia modifiers:
KLF1 (whole exons). BCL11A and HBS1L-MYB (point mutations).

Applications and Advantages

Applications

Research: Ideal for research laboratories studying the genetics of thalassemia and its modifiers. Complex variant detection: Including alpha globin deletions and mutations affecting fetal hemoglobin (HbF) production.

System Advantages

High CNV accuracy: Utilizes long-range PCR techniques and coverage analysis to ensure accuracy in CNV detection. Streamlined workflow: Sample library preparation with minimal hands-on time, suitable for high-throughput analysis. Intuitive software: Facilitates the interpretation of genetic data, reducing the need for intensive bioinformatics intervention.
Devyser Thalassemia Performance

Technical Specifications

Sample requirements

Sample type: Human genomic DNA. Requirements: Contaminant-free DNA, adequately concentrated for effective amplification.

Limitations

For research use only (RUO). Results only applicable to the specific processed samples. CNV detection can be affected by parameters such as DNA quality and concentration.

Area:

Hematology, Hereditary Blood Disorders, Hereditary and/or Rare Diseases, Molecular Genetics, Thalassemia

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR

VIASURE 16S V1-V4 NGS Solution

NGS solution for library preparation aimed at the simultaneous identification and profiling of microbial species present in DNA extracted from original samples, through the analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only (RUO) and not intended for diagnostic procedures. Detailed Description Principle of operation VIASURE 16S V1-V4…
Certest
Next Generation Sequencing (NGS)

PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture. Detailed Description The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the…
Pathonostics
Real Time PCR (qPCR)

Illumina Viral Surveillance Panel v2

Next‑generation sequencing (NGS) assay with hybrid capture enrichment for the detection and whole‑genome sequencing of approximately 200 RNA and DNA viruses relevant to public health. It integrates library preparation, enrichment, sequencing, and data analysis into an optimized workflow of about two days. Detailed Description Principle of operation The panel can start from RNA, DNA, or…
Illumina
Next Generation Sequencing (NGS)